Insider Monkey analyzed short selling data, revealing trends in US-listed stocks and sectors like technology. AstraZeneca PLC is highlighted as a strong stock with growth potential, supported by strategic decisions and promising drug portfolio. Hedge funds and analysts show confidence in AZN.